Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1979 3
1980 3
1981 6
1982 4
1983 8
1984 10
1985 12
1986 10
1987 7
1988 23
1989 22
1990 31
1991 44
1992 42
1993 54
1994 51
1995 55
1996 60
1997 73
1998 73
1999 75
2000 103
2001 116
2002 167
2003 186
2004 263
2005 363
2006 438
2007 496
2008 554
2009 647
2010 741
2011 908
2012 1082
2013 1278
2014 1564
2015 1749
2016 1770
2017 2099
2018 2424
2019 2842
2020 3590
2021 4216
2022 5192
2023 5283
2024 5024
2025 23

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39,312 results

Results by year

Filters applied: . Clear all
Page 1
Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.
Mok TS, Wu Y-L, Ahn M-J, Garassino MC, Kim HR, Ramalingam SS, Shepherd FA, He Y, Akamatsu H, Theelen WS, Lee CK, Sebastian M, Templeton A, Mann H, Marotti M, Ghiorghiu S, Papadimitrakopoulou VA; AURA3 Investigators. Mok TS, et al. Among authors: he y. N Engl J Med. 2017 Feb 16;376(7):629-640. doi: 10.1056/NEJMoa1612674. Epub 2016 Dec 6. N Engl J Med. 2017. PMID: 27959700 Free PMC article. Clinical Trial.
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial.
Wang ZX, Cui C, Yao J, Zhang Y, Li M, Feng J, Yang S, Fan Y, Shi J, Zhang X, Shen L, Shu Y, Wang C, Dai T, Mao T, Chen L, Guo Z, Liu B, Pan H, Cang S, Jiang Y, Wang J, Ye M, Chen Z, Jiang D, Lin Q, Ren W, Wang J, Wu L, Xu Y, Miao Z, Sun M, Xie C, Liu Y, Wang Q, Zhao L, Li Q, Huang C, Jiang K, Yang K, Li D, Liu Y, Zhu Z, Chen R, Jia L, Li W, Liao W, Liu HX, Ma D, Ma J, Qin Y, Shi Z, Wei Q, Xiao K, Zhang Y, Zhang Y, Chen X, Dai G, He J, Li J, Li G, Liu Y, Liu Z, Yuan X, Zhang J, Fu Z, He Y, Ju F, Liu Z, Tang P, Wang T, Wang W, Zhang J, Luo X, Tang X, May R, Feng H, Yao S, Keegan P, Xu RH, Wang F. Wang ZX, et al. Among authors: he y. Cancer Cell. 2022 Mar 14;40(3):277-288.e3. doi: 10.1016/j.ccell.2022.02.007. Epub 2022 Mar 3. Cancer Cell. 2022. PMID: 35245446 Free article. Clinical Trial.
Allodynia.
He Y, Kim PY. He Y, et al. 2023 Sep 4. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Sep 4. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 30725814 Free Books & Documents.
A designer peptide against the EAG2-Kvβ2 potassium channel targets the interaction of cancer cells and neurons to treat glioblastoma.
Dong W, Fekete A, Chen X, Liu H, Beilhartz GL, Chen X, Bahrampour S, Xiong Y, Yang Q, Zhao H, Kong T, Morioka MS, Jung G, Kim JE, Schramek D, Dirks PB, Song Y, Kim TH, He Y, Wanggou S, Li X, Melnyk RA, Wang LY, Huang X. Dong W, et al. Among authors: he y. Nat Cancer. 2023 Oct;4(10):1418-1436. doi: 10.1038/s43018-023-00626-8. Epub 2023 Sep 11. Nat Cancer. 2023. PMID: 37697045
Computational Quantification of Cancer Immunoediting.
Liu K, He S, Sun S, Zhang X, He Y, Quan F, Pang B, Xiao Y. Liu K, et al. Among authors: he y. Cancer Immunol Res. 2023 Sep 1;11(9):1159-1167. doi: 10.1158/2326-6066.CIR-22-0926. Cancer Immunol Res. 2023. PMID: 37540180 Review.
Autophagy in UV Damage Response.
Sample A, He YY. Sample A, et al. Among authors: he yy. Photochem Photobiol. 2017 Jul;93(4):943-955. doi: 10.1111/php.12691. Epub 2017 Jan 27. Photochem Photobiol. 2017. PMID: 27935061 Free PMC article. Review.
39,312 results
You have reached the last available page of results. Please see the User Guide for more information.